Trial Review | Colchicine After Stroke Event to Prevent Event Recurrence (CASPER): A randomised trial to evaluate the efficacy of oral Colchicine in high-risk patients with atherosclerosis-associated inflammation post-Stroke - Keech, A
ANZCTR.org. Accessed July 15, 2025 at: